The Long Road Ahead: A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer

2019 ◽  
Vol 31 (12) ◽  
pp. 537-539
Author(s):  
Jochen H. Lorch
Keyword(s):  
Thyroid Cancer ◽  
Initial Treatment ◽  
Anaplastic Thyroid Cancer ◽  
Phase 2 ◽  
Phase 2 Study

A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer

Thyroid ◽  
2019 ◽  
Vol 29 (11) ◽  
pp. 1615-1622 ◽  
Author(s):  
Ashish V. Chintakuntlawar ◽  
Jun Yin ◽  
Robert L. Foote ◽  
Jan L. Kasperbauer ◽  
Michael Rivera ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Initial Treatment ◽  
Anaplastic Thyroid Cancer ◽  
Phase 2 ◽  
Phase 2 Study

scholarly journals An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer

Thyroid ◽  
2020 ◽  
Vol 30 (9) ◽  
pp. 1254-1262
Author(s):  
Keith C. Bible ◽  
Michael E. Menefee ◽  
Chia-Chi (Josh) Lin ◽  
Michael J. Millward ◽  
William J. Maples ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Differentiated Thyroid Cancer ◽  
Radioactive Iodine ◽  
Phase 2 ◽  
Thyroglobulin Antibody ◽  
Phase 2 Study

Phase 2 study of cobicistat versus ritonavir each with once-daily atazanavir and fixed-dose emtricitabine/tenofovir df in the initial treatment of HIV infection

AIDS ◽  
2011 ◽  
Vol 25 (15) ◽  
pp. 1881-1886 ◽  
Author(s):  
Richard Elion ◽  
Calvin Cohen ◽  
Joseph Gathe ◽  
Peter Shalit ◽  
Trevor Hawkins ◽  
...  
Keyword(s):  
Hiv Infection ◽  
Initial Treatment ◽  
Fixed Dose ◽  
Phase 2 ◽  
Once Daily ◽  
Phase 2 Study ◽  
Tenofovir Df

scholarly journals Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer

Cancer ◽  
2019 ◽  
Vol 125 (17) ◽  
pp. 2984-2990 ◽  
Author(s):  
Eric J. Sherman ◽  
Lara A. Dunn ◽  
Heiko Schöder ◽  
Alan L. Ho ◽  
Shrujal S. Baxi ◽  
...  
Keyword(s):  
Vascular Endothelial Growth Factor ◽  
Thyroid Cancer ◽  
Growth Factor ◽  
Vascular Endothelial ◽  
Phase 2 ◽  
Phase 2 Study ◽  
Endothelial Growth Factor ◽  
Metastatic Thyroid Cancer

scholarly journals Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer

Cancer ◽  
2017 ◽  
Vol 123 (21) ◽  
pp. 4114-4121 ◽  
Author(s):  
Eric J. Sherman ◽  
Lara A. Dunn ◽  
Alan L. Ho ◽  
Shrujal S. Baxi ◽  
Ronald A. Ghossein ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Radioactive Iodine ◽  
Phase 2 ◽  
Phase 2 Study
Sign in / Sign up

Export Citation Format

Share Document